Biohaven has appointed John Yetimoglu to its Board of Directors, effective immediately. Yetimoglu is the founder and Chief Investment Officer of Infinitum, an investment firm specializing in semiconductors, videogaming, and next-generation AI application platforms, and serves as a director on the board of Groq, a leader in AI inference computing. His appointment brings frontier AI and technology-investing expertise to Biohaven as the company advances AI-enabled approaches to drug development. Biohaven expects the convergence of biology, data, and computation to drive the next wave of medical breakthroughs, and Yetimoglu's perspective is intended to strengthen the Board's strategic oversight in these areas.
Biohaven Ltd.Appointment of AI technology investor to board to advance AI-enabled drug development.
NVIDIA CorporationFounder's appointment to Biohaven board may enhance Infinitum's strategic influence.
